| Dr Brian Timothy O'hollaren, MD | |
|
2090 Ne Wyatt Ct, Suite 101, Bend, OR 97701-7687 | |
| (541) 382-6447 | |
| (541) 330-7413 |
| Full Name | Dr Brian Timothy O'hollaren |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 2090 Ne Wyatt Ct, Bend, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629030523 | NPI | - | NPPES |
| 095547 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD15929 (Oregon) | Primary |
| Entity Name | Bend Memorial Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699827477 PECOS PAC ID: 7214936533 Enrollment ID: O20061215000022 |
News Archive
Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a non-binding Letter of Intent with the National Institute on Drug Abuse (NIDA) to conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. It is anticipated that NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the trial and that Catalyst will contribute approximately $2.5 million in resources as part of the estimated $10 million trial cost.
Various types of information can be ascertained by the way blood flows through the brain. When a region of the brain has been activated, blood flow increases and oxygenation rises. By observing variations in blood flow with the help of non-invasive imaging, it is possible to determine which regions are at work at a given point in time and how they work together.
Thanks to new methods of precision diagnostics, such as DNA sequencing and epigenetic analyses, it is becoming increasingly possible to identify specific central nervous system (CNS) tumors accurately and to provide targeted treatment. The Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital is one of the top centers in the world for diagnosing and treating this type of tumor.
An investigation into why some babies grow only very slowly in the first nine months of their lives has come to the conclusion that it has nothing to do with the prosperity of the parents.
New research from University of California, Davis, shows why a species of tiny worm can learn to ignore an odor – information that could have implications for how human memories are formed.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Timothy O'hollaren, MD 2090 Ne Wyatt Ct, Suite 101, Bend, OR 97701-7687 Ph: (541) 382-6447 | Dr Brian Timothy O'hollaren, MD 2090 Ne Wyatt Ct, Suite 101, Bend, OR 97701-7687 Ph: (541) 382-6447 |
News Archive
Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a non-binding Letter of Intent with the National Institute on Drug Abuse (NIDA) to conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. It is anticipated that NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the trial and that Catalyst will contribute approximately $2.5 million in resources as part of the estimated $10 million trial cost.
Various types of information can be ascertained by the way blood flows through the brain. When a region of the brain has been activated, blood flow increases and oxygenation rises. By observing variations in blood flow with the help of non-invasive imaging, it is possible to determine which regions are at work at a given point in time and how they work together.
Thanks to new methods of precision diagnostics, such as DNA sequencing and epigenetic analyses, it is becoming increasingly possible to identify specific central nervous system (CNS) tumors accurately and to provide targeted treatment. The Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital is one of the top centers in the world for diagnosing and treating this type of tumor.
An investigation into why some babies grow only very slowly in the first nine months of their lives has come to the conclusion that it has nothing to do with the prosperity of the parents.
New research from University of California, Davis, shows why a species of tiny worm can learn to ignore an odor – information that could have implications for how human memories are formed.
› Verified 2 days ago
Dr. Matt S Ashley, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2090 Ne Wyatt Ct Ste 101, Bend, OR 97701 Phone: 541-382-6447 Fax: 541-330-7413 | |
Dr. Daniel Levi Willis, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2090 Ne Wyatt Ct Ste 101, Bend, OR 97701 Phone: 541-382-6447 | |
Andrew David Neeb, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 431 Ne Revere Ave Ste 200, Bend, OR 97701 Phone: 541-508-7973 Fax: 541-508-7968 | |
Hagop Sarkissian, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2090 Ne Wyatt Ct Ste 101, Bend, OR 97701 Phone: 541-382-6447 | |
Dr. Meredith Rae Baker, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2090 Ne Wyatt Ct, Suite 101, Bend, OR 97701 Phone: 541-382-6447 Fax: 541-330-7413 | |
Dr. Michel Adeodat Boileau, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2090 Ne Wyatt Ct, Suite 101, Bend, OR 97701 Phone: 541-382-6447 Fax: 541-330-7413 | |
Dr. Jack Alan Brewer, MD Urology Medicare: Medicare Enrolled Practice Location: 2090 Ne Wyatt Ct, Suite 101, Bend, OR 97701 Phone: 541-382-6447 Fax: 541-330-7413 |